Thoma Bravo has acquired Mediware Information Systems, a provider of clinical software, for $195 million. Under the terms of the pending agreement, shareholders will receive $22 in cash for each share of Mediware common stock. The transaction is expected to close before the end of the year.
Mediware Information Systems designs, develops and markets software used by healthcare institutions in clinical and performance management, blood donor management , blood and biologic management, and medication management. The company was founded in 1970 and is based in Lenexa, KS (www.mediware.com).
Thoma Bravo provides equity and strategic support to management teams building growing companies. The firm originated the concept of industry consolidation investing, which seeks to create value through the strategic use of acquisitions to accelerate business growth. Thoma Bravo currently manages approximately $4 billion of equity capital. The firm was founded in 1981 and has offices in Chicago, IL and San Francisco, CA (www.thomabravo.com).
Herrick, Feinstein LLP, a law firm based in New York, represented Mediware Information Systems in this transaction. The Herrick deal team was led by Irwin Kishner, Chairman of Herrick’s Executive Committee and Co-Chairman of the firm’s Corporate Department, and included Partners Stephen Fox and Harold Levine (tax) as well as Counsel Fred Green (benefits) and Sung Hwang (tax) and Associate Liliana Chang (www.herrick.com).
© 2012 PEPD • Private Equity’s Leading News Magazine • 9-19-12